Statera BioPharma is a clinical-stage biopharmaceutical company focused on developing novel immunotherapies to treat autoimmune diseases, cancers, and emerging viruses. The company leverages a proprietary platform designed to rebalance the immune system and restore homeostasis, aiming to provide next-generation immune therapies.